ApoE e4

Genetic variant present in 20% of the population, multiplying Alzheimer's risk by 3-4 (heterozygous) to 8-12 (homozygous). Reduces Aβ clearance and amplifies neuroinflammation. Paradoxically, these carriers also benefit most from exercise (45% risk reduction).